Not available
Quote | Sangamo Therapeutics Inc. (NASDAQ:SGMO)
Last: | $0.5115 |
---|---|
Change Percent: | 1.32% |
Open: | $0.4787 |
Close: | $0.5115 |
High: | $0.5291 |
Low: | $0.4701 |
Volume: | 1,034,432 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Sangamo Therapeutics Inc. (NASDAQ:SGMO)
2024-04-02 11:36:00 ET More on CRISPR Therapeutics Crispr Therapeutics: I'm Not Betting Against Gene Editing This Time (Upgrade) Crispr Therapeutics: Cautiously Optimistic CRISPR Therapeutics AG (CRSP) Presents at Citi 2024 Virtual Oncology Leadership Summit Conferen...
2024-03-22 08:21:15 ET More on Sangamo Therapeutics Sangamo Therapeutics GAAP EPS of -$0.34 misses by $0.08, revenue of $2.04M misses by $6.07M Sangamo stock soars 37% on updates for Fabry disease therapy Read the full article on Seeking Alpha For further det...
Message Board Posts | Sangamo Therapeutics Inc. (NASDAQ:SGMO)
Subject | By | Source | When |
---|---|---|---|
znewcar1: $SGMO 20% v5,1M c1.64 f192,9MH1.6795 ML1.35=LL | znewcar1 | investorshangout | 04/13/2023 9:33:16 PM |
I'm not ready to put a fork in | The Canes | investorshub | 03/29/2023 3:43:01 PM |
The company is essentially dead. | jondoeuk | investorshub | 03/17/2023 11:44:30 PM |
A double whammy https://www.marketscreener.com/quote/stock/SANGAMO-THERAPEUTICS- | jondoeuk | investorshub | 03/17/2023 11:43:59 PM |
Are you familiar with EDIT? How well they | jondoeuk | investorshub | 02/17/2023 1:37:43 AM |
News, Short Squeeze, Breakout and More Instantly...
Sangamo Therapeutics Inc. Company Name:
SGMO Stock Symbol:
NASDAQ Market:
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase and sale of an aggregate of 24,761,905 shares of its common stock and pre-funded warrants to pur...
H.C. Wainwright initiated coverage on Voyager Therapeutics Inc (NASDAQ:VYGR), noting a growing franchise of novel, highly-differenti...
2024-03-13 15:30:02 ET H.C. Wainwright analyst issues BUY recommendation for SGMO on March 13, 2024 02:00PM ET. The previous analyst recommendation was Buy. SGMO was trading at $0.801 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...